Acetylcholinesterase Inhibitors and drugs acting on muscarinic receptors-potential crosstalk of cholinergic mechanisms during pharmacological treatment

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023752%3A_____%2F17%3A43919242" target="_blank" >RIV/00023752:_____/17:43919242 - isvavai.cz</a>
Result on the web
<a href="http://www.eurekaselect.com/143096/article" target="_blank" >http://www.eurekaselect.com/143096/article</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2174/1570159X14666160607212615" target="_blank" >10.2174/1570159X14666160607212615</a>

Result language
angličtina
Original language name
Acetylcholinesterase Inhibitors and drugs acting on muscarinic receptors-potential crosstalk of cholinergic mechanisms during pharmacological treatment
Original language description
Background: Pharmaceuticals with targets in the cholinergic transmission have been used for decades and are still fundamental treatments in many diseases and conditions today. Both the transmission and the effects of the somatomotoric and the parasympathetic nervous systems may be targeted by such treatments. Irrespective of the knowledge that the effects of neuronal signalling in the nervous systems may include a number of different receptor subtypes of both the nicotinic and the muscarinic receptors, this complexity is generally overlooked when assessing the mechanisms of action of pharmaceuticals.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10403 - Physical chemistry

Project
<a href="/en/project/ED2.1.00%2F03.0078" target="_blank" >ED2.1.00/03.0078: National institute of Mental Health</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)